1. Kusmartsev, S., Li, Y., & Chen, S.-H. (2000). Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. Journal of Immunology, 165, 779–785.
2. Melani, C., Chiodoni, C., Forni, G., & Colombo, M. P. (2003). Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood, 102, 2138–2145.
3. Kusmartsev, S., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E., & Lush, R., et al. (2003). All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Research, 63, 4441–4449.
4. Salvadori, S., Martinelli, G., & Zier, K. (2000). Resection of solid tumors reverses T cell defects and restores protective immunity. Journal of Immunology, 164, 2214.
5. Young, M. R. I., Newby, M., & Wepsic, T. H. (1987). Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors. Cancer Research, 47, 100–106.